In the pharmaceutical industry, data is a critical asset that drives innovation, efficiency, and precision across drug discovery and development. Effectively capturing, analyzing, and sharing vast research datasets enables organizations to identify novel therapeutic targets and advance drug candidates more quickly and efficiently. Collaboration—both within the organization and with external partners, including academic institutions and CROs/CDMOs is equally essential. These partnerships depend on secure, seamless data sharing and enable the exchange of expertise, resources, and advanced analytical capabilities. By streamlining collaboration and accelerating access to insights, organizations can shorten development timelines, reduce costs, and ultimately bring new medicines to patients faster. 

Scilligence’s informatics solutions combine native cheminformatics and bioinformatics technologies in a unified platform designed to meet the complex data and workflow needs of modern pharmaceutical research. The platform enables organizations to efficiently capture and manage data, automate workflows, track tasks and projects in real time, and manage research materials cost-effectively. Supporting a broad range of therapeutic modalities, including peptides, oligonucleotides, and drug conjugates such as antibody-drug conjugates (ADCs), Scilligence provides a comprehensive foundation for advancing research and development from discovery through development.